Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
01 3Helvepharm Ag
02 11Orion Corporation
03 51 A Pharma Gmbh
04 51A Pharma Gmbh
05 32Care4 Aps
06 23M Health Care Ltd
07 1Ababor Pharmaceuticals Sl
08 2Abacus Medicine A/S
09 2Acino Ag
10 13Actavis Group Ptc Ehf.
11 8Almirall Sa
12 2Amw Gmbh
13 4Arrow Aps
14 4Aurobindo Laboratories Slu
15 1Cinfa Laboratories Sa
16 5Combix Laboratories Slu
17 5Ebb Medical Ab
18 5Elpen Pharmaceutical Co. Inc
19 5Farmalider Sa
20 1Galenicum Derma Sl
21 10Hexal Ag
22 5Kern Pharma Sl
23 17Krka Dd Novo Mesto
24 8Krka Dd, Novo Mesto
25 2Luye Pharma Switzerland Ag
26 1Medartuum Ab
27 3Mepha Pharma Ag
28 6Mylan Ab
29 4Normon Laboratories Sa
30 13Novartis Europharm Limited
31 8Novartis Pharma Schweiz Ag
32 7Orifarm Generics A/S
33 4Ratiopharm Gmbh
34 3Sandoz A/S
35 16Sandoz Gmbh
36 3Sandoz Pharmaceuticals Ag
37 4Sandoz Pharmaceuticals Gmbh
38 9Stada Pharmaceuticals Ag
39 4Stada Sl Laboratory
40 5Synthon Bv
41 3Teva Bv
42 4Teva Pharma Bv
43 1Torrefarma Sl
44 1Vegal Farmaceutica Sl
45 4Viatris Limited
46 2Vir Sa Chemical And Pharmaceutical Industry
47 5World Medicine Ilac San ve tic LTD STl
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Allowed
Registration Country : Switzerland
Brand Name : Rivastigmine Zentiva Patch h
Dosage Form : Transdermal Patch
Dosage Strength : 4.6mg/24hours
Packaging :
Approval Date : 27/03/2014
Application Number : 62917
Regulatory Info : Allowed
Registration Country : Switzerland
Regulatory Info : Prescription
Registration Country : Denmark
Rivastigmine Hydrogen Tartrate
Brand Name : Rivastigmine \"Orion\"
Dosage Form : Hard Capsules
Dosage Strength : 1.5mg
Packaging :
Approval Date : 18-06-2009
Application Number : 28104342008
Regulatory Info : Prescription
Registration Country : Denmark
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Allowed
Registration Country : Switzerland
Brand Name : Rivastigmine Zentiva Patch h
Dosage Form : Transdermal Patch
Dosage Strength : 9.5mg/24hours
Packaging :
Approval Date : 27/03/2014
Application Number : 62917
Regulatory Info : Allowed
Registration Country : Switzerland
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Allowed
Registration Country : Switzerland
Brand Name : Rivastigmine Zentiva Patch h
Dosage Form : Transdermal Patch
Dosage Strength : 13.3mg/24hours
Packaging :
Approval Date : 27/03/2014
Application Number : 62917
Regulatory Info : Allowed
Registration Country : Switzerland
Regulatory Info : Prescription
Registration Country : Denmark
Rivastigmine Hydrogen Tartrate
Brand Name : Rivastigmine \"Orion\"
Dosage Form : Hard Capsules
Dosage Strength : 3mg
Packaging :
Approval Date : 18-06-2009
Application Number : 28104342108
Regulatory Info : Prescription
Registration Country : Denmark
Regulatory Info : Prescription
Registration Country : Denmark
Rivastigmine Hydrogen Tartrate
Brand Name : Rivastigmine \"Orion\"
Dosage Form : Hard Capsules
Dosage Strength : 4.5mg
Packaging :
Approval Date : 18-06-2009
Application Number : 28104342208
Regulatory Info : Prescription
Registration Country : Denmark
Regulatory Info : Prescription
Registration Country : Denmark
Rivastigmine Hydrogen Tartrate
Brand Name : Rivastigmine \"Orion\"
Dosage Form : Hard Capsules
Dosage Strength : 6mg
Packaging :
Approval Date : 18-06-2009
Application Number : 28104342308
Regulatory Info : Prescription
Registration Country : Denmark
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Rivastor
Dosage Form : Transdermal Patch
Dosage Strength : 4.6mg/24hours
Packaging :
Approval Date : 13-06-2013
Application Number : 2.01E+13
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Rivastor
Dosage Form : Transdermal Patch
Dosage Strength : 9.5mg/24hours
Packaging :
Approval Date : 13-06-2013
Application Number : 2.01E+13
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Rivastor
Dosage Form : Transdermal Patch
Dosage Strength : 13.3mg/24hours
Packaging :
Approval Date : 15-01-2020
Application Number : 2.02E+13
Regulatory Info : Approved
Registration Country : Sweden
